CJC-1295 with DAC certificate of analysis, lot PL-2610-049
Certificate PL-26-00171 reports the release tests for CJC-1295 with DAC lot PL-2610-049: 99.46% purity by reverse-phase HPLC and identity confirmed by LC-MS, tested October 5, 2026. The lot number printed on each unit matches this certificate.
| Certificate number | PL-26-00171 |
|---|---|
| Lot number | PL-2610-049 |
| Compound | CJC-1295 with DAC 5 mg |
| Sequence | H-Y-[D-Ala]-DAIFTQSYRKVLAQLSARKLLQDILSR-K(Nε-3-maleimidopropionyl)-NH₂ (30 residues; C-terminal amide; the maleimide couples to serum albumin Cys34 in vivo) |
| Molecular formula | C165H269N47O46 |
| CAS number | 446262-90-4 |
| Purity (RP-HPLC) | 99.46% |
| Identity (LC-MS) | Conforms (3,647.28 Da) · expected 3647.2 Da, found 3647.28 Da |
| Method | RP-HPLC (UV 214 nm) + LC-MS |
| Tested | October 5, 2026 |
| Retest by | October 2, 2028 |
| Tested by | Manufacturer’s in-house laboratory (not an independent third-party test) |
| Conclusion | Conforms |
Tests run on this lot
| Test | Method | Specification | Result |
|---|---|---|---|
| Identity (mass) | LC-MS, ESI positive | Theoretical ± 1.0 Da | 3,647.28 Da (PASS) |
| Purity | RP-HPLC, UV 214 nm, area% | ≥ 99.0% | 99.46% (PASS) |
| Largest impurity | RP-HPLC, area% | ≤ 1.0% | 0.25% (RT 16.90) (PASS) |
| Water content | Karl Fischer | ≤ 5.0% | 2.45% (PASS) |
| Bacterial endotoxin | LAL, kinetic | ≤ 5.0 EU/mg | 0.178 EU/mg (PASS) |
| Sterility | USP <71>, 14-day | No growth | No growth (PASS) |
What these results mean
HPLC purity is the share of UV-detectable material that elutes as the target compound; it is not the same as net peptide content, which also accounts for water and counter-ions. Identity means the measured mass matched the mass calculated for the compound. A certificate reports only the tests run on this lot; endotoxin, sterility and contaminant panels are not part of standard lot release. How to read a certificate of analysis.
CJC-1295 with DAC · Verify this certificate · All certificates
All CJC-1295 with DAC certificates
Other CJC-1295 with DAC lots
- PL-26-00025, lot PL-2609-025, 99.78%, tested September 18, 2026
All products currently listed on this site are for research purposes only. Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption. Products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure or prevent any disease.